Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. - Wikidata - awgldk - TriplyDB

Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis.

Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis.

http://www.wikidata.org/entity/Q36059617

about

Overview of the biology of type I interferons Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus Accelerated atherosclerosis in patients with SLE--mechanisms and management Neutrophils in the pathogenesis and manifestations of SLE Cardiovascular disease in lupus: insights and updates Type I interferon: friend or foe?The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.The effect of type 1 IFN on human aortic endothelial cell function in vitro: relevance to systemic lupus erythematosus.Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound Rheumatic autoimmune diseases in women and midlife health Management of cardiovascular complications in systemic lupus erythematosus.Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis.An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2 A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.Monocyte activation from interferon-α in HIV infection increases acetylated LDL uptake and ROS production Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine Determinants of vascular function in patients with chronic gout.Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells.Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells.The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus.The effect of acute exposure to coarse particulate matter air pollution in a rural location on circulating endothelial progenitor cells: results from a randomized controlled study.Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions Interferon-α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia.The type I interferon system in the etiopathogenesis of autoimmune diseases.Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.Cytokine disturbances in systemic lupus erythematosus.MAb therapy against the IFN-α/β receptor subunit 1 stimulates arteriogenesis in a murine hindlimb ischaemia model without enhancing atherosclerotic burden.Interleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon α on lupus endothelial cell progenitors Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent.Endothelial progenitor cell phenotype and function are impaired in childhood-onset systemic lupus erythematosus.Role of interferon alpha in endothelial dysfunction: insights into endothelial nitric oxide synthase-related mechanisms Plasmacytoid dendritic cells in atherosclerosis.

P2860

Q21195364-67912774-12AD-449B-8AB5-569473A37DE8 Q24612339-24AB5C99-6842-449E-B087-B6E5AC6F5A22 Q26782454-B8270291-3581-45F5-83F0-63E4847E39DB Q26820245-8FCEC03C-9137-4F6D-965A-A8BA7B67C95C Q27000384-BB12F845-0BBF-427D-89D0-9A7534B0B9C9 Q27016554-9ADBCA3A-2CAF-4C5B-997E-63F94C4BE073 Q28293186-EC0DFF6F-D8C6-4548-B72C-411FB17ECDFC Q30497355-139E518C-0FE7-47B5-8BE6-88C53085A923 Q33387473-C6D6B902-B2C2-4DE5-9555-FD56D1A148EB Q33588015-18D0A74C-9FC4-488C-BC33-8051C100648C Q33704086-FCC3C082-12AB-401F-908E-7400028A9EE1 Q33727015-7C53A5A7-6A0F-4111-A9C5-514C0869416A Q33730536-6DD1EC3A-1AAB-43FC-A792-002A9878383E Q34015433-C1CE3DB2-F924-4A8B-B921-48F1FE70A24D Q34055844-DBA8EB20-DB5F-412F-BEC0-22D9A364FFA0 Q34084599-85EA649A-F3BE-455E-B38C-5D0413C72CC2 Q34089816-5F162A58-3EDF-44BA-A0E4-0D7FF630B098 Q34127758-2CABE1B2-5494-41B4-806C-F67E658AFDB8 Q34170097-526AFD1B-80F9-4C42-A0F3-7C9FA72B1BCC Q34240254-0EA158F1-5B64-4A19-AF1C-6D87BA531AE6 Q34273836-67A1361F-BF60-4967-A084-AA1424D01E31 Q34292033-4FC120B7-59D4-4A7E-8B6C-577C8264D12E Q34343906-C053771A-1B26-4C70-938F-7AE882311C95 Q34635470-82F4862F-A237-4251-BF7E-0D3087C4B13A Q34788956-DDD1133D-E1D4-47C9-ACB5-B9D5F8596348 Q35145964-08F4601C-2FB4-4025-8412-3279D0018705 Q35152132-5408572A-525C-4CBA-A6A9-F12A7BE62C70 Q35169351-A09E70E4-A6A7-4CC8-B8C7-8D2E77E3F841 Q35191332-A57270B7-1904-4016-9354-26BDE0613522 Q35214718-F440720E-C763-48D7-AEF8-CD575C17499A Q35236547-74B4746B-EC98-418D-9492-D54DC7F89833 Q35514368-B59AA064-C824-4C99-A86E-B5C5D77A4153 Q35566819-A94CDFE0-74B4-4406-B0FD-0FC6CA249FE9 Q35617573-65B03BD0-CFF4-4341-AC39-FC260C062137 Q35620995-27F86F5F-BA57-4FEB-8DA9-7061D5CC9071 Q35661943-BF1032E2-EBFC-45E8-96FE-9027244727C8 Q35774189-AD20C0AC-A952-43A8-A4D3-3840C4F1EC5F Q35901110-FC987E54-5020-4D0F-9F41-ADDA01EE9F36 Q35920339-72FB3B71-510D-4B54-9874-1A26A18DB431 Q36064574-504E3574-CAE3-48DE-AE3F-755DB96A2B17

P2860

Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis.

http://www.wikidata.org/entity/Q36059617

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Interferon-alpha promotes abno ...... for premature atherosclerosis.

@ast

Interferon-alpha promotes abno ...... for premature atherosclerosis.

@en

type

label

Interferon-alpha promotes abno ...... for premature atherosclerosis.

@ast

Interferon-alpha promotes abno ...... for premature atherosclerosis.

@en

prefLabel

Interferon-alpha promotes abno ...... for premature atherosclerosis.

@ast

Interferon-alpha promotes abno ...... for premature atherosclerosis.

@en

P1433

Q36059617-D7AF1C7F-EFF5-4789-A076-A54851F4642A

P1476

Q36059617-D6CB0EC1-731F-40E9-BFCD-CAD7379264A8

P2093

Q36059617-280E5791-82BC-4B73-B518-B73995B010D6

Q36059617-5BC674F5-20C6-458F-9538-E38117D956AB

Q36059617-97C9291B-16ED-40F8-84B7-72335D8D62B5

Q36059617-9D8FE6EE-8291-49A7-9E24-163A18BD6E0C

Q36059617-ADA1CFA1-9BC9-43AB-ABA0-30A5CF31B979

Q36059617-BA991D0D-E424-44A7-9540-E91029A62831

Q36059617-F9AFFB84-F94D-442D-AEA0-DF3F2DC43D6E

P2860

Q36059617-0662136D-D0A3-4C66-84BB-8FEA935F5588

Q36059617-073B1267-33EA-48C1-945D-E4D861618B58

Q36059617-08FAA17E-6A14-4269-80B8-F28E021B4CA9

Q36059617-0EB4CB53-A486-4052-BA75-30D44C5D0E78

Q36059617-13748E67-276E-405A-96E5-8164918BED12

Q36059617-163A93A4-5DD2-4379-A663-7A523395B9EE

Q36059617-1804BC08-B655-4E48-ADF9-2EF3E33397F8

Q36059617-1ADA2159-528C-4B85-9A5C-F0C730A92973

Q36059617-1AF2D7A4-C10C-4A4C-B95B-690EF6724AD0

Q36059617-23AC7FD2-EA16-4876-8A2D-36D9F9BFB1C7

P304

Q36059617-8F85FC17-1AF3-4C68-9E61-63D762E350A7

P31

Q36059617-29B648FD-F5B1-4DCB-B562-F0F41EA6984E

P356

Q36059617-F454E728-9434-4E4B-AC4E-4E9D7C842932

P407

Q36059617-C4924EED-AE7B-484D-A290-A15ABC9ADE87

P433

Q36059617-71D7E131-EF1D-4EC1-A8F2-877DE9647CDA

P478

Q36059617-5C4A5A0E-FCF8-4276-A053-6BDDCB1EEDB4

P50

Q36059617-9A3A8B97-C4B8-4191-BB0A-17D84751BE77

P577

Q36059617-FA45915B-970E-4ADC-BDB2-72DC3BDB521E

P5875

Q36059617-66325F39-9CA3-4DFF-8842-EF314C95F79B

P698

Q36059617-B8F3B5B2-818E-45AE-B9A3-830BD7A2570D

P921

Q36059617-E6761C6B-FE3F-41CE-90EB-54373C82B417

P932

Q36059617-CB2695F5-4575-47C2-8980-919E3BF51A2E

P356

BLOOD-2007-05-089086

P1433

P1476

Interferon-alpha promotes abno ...... for premature atherosclerosis.

@en

P2093

Franck J Barrat

http://www.w3.org/2001/XMLSchema#string

Hemal Mehta

http://www.w3.org/2001/XMLSchema#string

Mariana J Kaplan

http://www.w3.org/2001/XMLSchema#string

Michael F Denny

http://www.w3.org/2001/XMLSchema#string

Seth Thacker

http://www.w3.org/2001/XMLSchema#string

Todd Dodick

http://www.w3.org/2001/XMLSchema#string

W Joseph McCune

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant IFN-alpha (2b) increases the expression of apoptosis receptor CD95 and chemokine receptors CCR1 and CCR3 in monocytoid cells

IL-4 and IL-13 induce protection of porcine endothelial cells from killing by human complement and from apoptosis through activation of a phosphatidylinositide 3-kinase/Akt pathway

Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration

The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells

Circulating endothelial progenitor cells and cardiovascular outcomes

The 1982 revised criteria for the classification of systemic lupus erythematosus

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells.

Interferon alpha-2a for proliferative diabetic retinopathy after complete laser panretinal photocoagulation treatment.

Cytokines and vascular permeability: an in vitro study on human endothelial cells in relation to tumor necrosis factor-alpha-primed peripheral blood mononuclear cells.

P304

2907-2915

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2007-05-089086

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6199427

http://www.w3.org/2001/XMLSchema#string

P698

17638846

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

2018671

http://www.w3.org/2001/XMLSchema#string